Literature DB >> 23752613

Neutrophil recruitment to the lung in both C5a- and CXCL1-induced alveolitis is impaired in vitamin D-binding protein-deficient mice.

Glenda Trujillo1, David M Habiel, Lingyin Ge, Mahalakshmi Ramadass, Nancy E Cooke, Richard R Kew.   

Abstract

Knowledge of how neutrophils respond to chemotactic signals in a complex inflammatory environment is not completely understood. Moreover, even less is known about factors in physiological fluids that regulate the activity of chemoattractants. The vitamin D-binding protein (DBP) has been shown to significantly enhance chemotaxis to complement activation peptide C5a using purified proteins in vitro, and by ex vivo depletion of DBP in physiological fluids, but this function has not been determined in vivo. DBP null ((-/-)) mice were used to investigate how a systemic absence of this plasma protein affects leukocyte recruitment in alveolitis models of lung inflammation. DBP(-/-) mice had significantly reduced (~50%) neutrophil recruitment to the lungs compared with their wild-type DBP(+/+) counterparts in three different alveolitis models, two acute and one chronic. The histology of DBP(-/-) mouse lungs also showed significantly less injury than wild-type animals. The chemotactic cofactor function of DBP appears to be selective for neutrophil recruitment, but, in contrast to previous in vitro results, in vivo DBP can enhance the activity of other chemoattractants, including CXCL1. The reduced neutrophil response in DBP(-/-) mice could be rescued to wild-type levels by administering exogenous DBP. Finally, in inflammatory fluids, DBP binds to G-actin released from damaged cells, and this complex may be the active chemotactic cofactor. To our knowledge, results show for the first time that DBP is a significant chemotactic cofactor in vivo and not specific for C5a, suggesting that this ubiquitous plasma protein may have a more significant role in neutrophil recruitment than previously recognized.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23752613      PMCID: PMC3702662          DOI: 10.4049/jimmunol.1202941

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  51 in total

Review 1.  Complement: a key system for immune surveillance and homeostasis.

Authors:  Daniel Ricklin; George Hajishengallis; Kun Yang; John D Lambris
Journal:  Nat Immunol       Date:  2010-08-19       Impact factor: 25.606

2.  Upregulation of vitamin D binding protein (Gc-globulin) binding sites during neutrophil activation from a latent reservoir in azurophil granules.

Authors:  Stephen J DiMartino; Glenda Trujillo; Lauren A McVoy; Jianhua Zhang; Richard R Kew
Journal:  Mol Immunol       Date:  2006-11-20       Impact factor: 4.407

3.  Identification of two distinct cell binding sequences in the vitamin D binding protein.

Authors:  Jianhua Zhang; David M Habiel; Mahalakshmi Ramadass; Richard R Kew
Journal:  Biochim Biophys Acta       Date:  2010-03-06

4.  Generation of C5a in the absence of C3: a new complement activation pathway.

Authors:  Markus Huber-Lang; J Vidya Sarma; Firas S Zetoune; Daniel Rittirsch; Thomas A Neff; Stephanie R McGuire; John D Lambris; Roscoe L Warner; Michael A Flierl; Laszlo M Hoesel; Florian Gebhard; John G Younger; Scott M Drouin; Rick A Wetsel; Peter A Ward
Journal:  Nat Med       Date:  2006-05-21       Impact factor: 53.440

Review 5.  Murine models of pulmonary fibrosis.

Authors:  Bethany B Moore; Cory M Hogaboam
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2007-11-09       Impact factor: 5.464

6.  Tonic inhibition of chemotaxis in human plasma.

Authors:  Stephen E Malawista; Anne de Boisfleury Chevance; Jo van Damme; Charles N Serhan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-11-07       Impact factor: 11.205

7.  Oropharyngeal aspiration: an alternative route for challenging in a mouse model of chemical-induced asthma.

Authors:  Vanessa De Vooght; Jeroen A J Vanoirbeek; Steven Haenen; Erik Verbeken; Benoit Nemery; Peter H M Hoet
Journal:  Toxicology       Date:  2009-02-28       Impact factor: 4.221

8.  A novel mechanism for CCR4 in the regulation of macrophage activation in bleomycin-induced pulmonary fibrosis.

Authors:  Glenda Trujillo; Erica C O'Connor; Steven L Kunkel; Cory M Hogaboam
Journal:  Am J Pathol       Date:  2008-04-10       Impact factor: 4.307

9.  Vitamin D-binding protein influences total circulating levels of 1,25-dihydroxyvitamin D3 but does not directly modulate the bioactive levels of the hormone in vivo.

Authors:  Lee A Zella; Nirupama K Shevde; Bruce W Hollis; Nancy E Cooke; J Wesley Pike
Journal:  Endocrinology       Date:  2008-03-27       Impact factor: 4.736

Review 10.  Animal models of acute lung injury.

Authors:  Gustavo Matute-Bello; Charles W Frevert; Thomas R Martin
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-07-11       Impact factor: 5.464

View more
  21 in total

1.  Enhanced Resolution of Hyperoxic Acute Lung Injury as a result of Aspirin Triggered Resolvin D1 Treatment.

Authors:  Ruan Cox; Oluwakemi Phillips; Jutaro Fukumoto; Itsuko Fukumoto; Prasanna Tamarapu Parthasarathy; Stephen Arias; Young Cho; Richard F Lockey; Narasaiah Kolliputi
Journal:  Am J Respir Cell Mol Biol       Date:  2015-09       Impact factor: 6.914

2.  Experimental design of complement component 5a-induced acute lung injury (C5a-ALI): a role of CC-chemokine receptor type 5 during immune activation by anaphylatoxin.

Authors:  Norman F Russkamp; Robert Ruemmler; Julian Roewe; Bethany B Moore; Peter A Ward; Markus Bosmann
Journal:  FASEB J       Date:  2015-05-21       Impact factor: 5.191

3.  Deficiency of the two-pore-domain potassium channel TREK-1 promotes hyperoxia-induced lung injury.

Authors:  Andreas Schwingshackl; Bin Teng; Patrudu Makena; Manik Ghosh; Scott E Sinclair; Charlean Luellen; Louisa Balasz; Cynthia Rovnaghi; Robert M Bryan; Eric E Lloyd; Elizabeth Fitzpatrick; Jordy S Saravia; Stephania A Cormier; Christopher M Waters
Journal:  Crit Care Med       Date:  2014-11       Impact factor: 7.598

4.  Vitamin D-Binding Protein Deficiency and Homozygous Deletion of the GC Gene.

Authors:  Clark M Henderson; Susan L Fink; Hanan Bassyouni; Bob Argiropoulos; Lindsay Brown; Thomas J Laha; Konner J Jackson; Raymond Lewkonia; Patrick Ferreira; Andrew N Hoofnagle; Julien L Marcadier
Journal:  N Engl J Med       Date:  2019-03-21       Impact factor: 91.245

Review 5.  Protein-based therapies for acute lung injury: targeting neutrophil extracellular traps.

Authors:  Markus Bosmann; Peter A Ward
Journal:  Expert Opin Ther Targets       Date:  2014-03-26       Impact factor: 6.902

Review 6.  Vitamin D: Metabolism, Molecular Mechanism of Action, and Pleiotropic Effects.

Authors:  Sylvia Christakos; Puneet Dhawan; Annemieke Verstuyf; Lieve Verlinden; Geert Carmeliet
Journal:  Physiol Rev       Date:  2016-01       Impact factor: 37.312

7.  Attenuation of pulmonary ACE2 activity impairs inactivation of des-Arg9 bradykinin/BKB1R axis and facilitates LPS-induced neutrophil infiltration.

Authors:  Chhinder P Sodhi; Christine Wohlford-Lenane; Yukihiro Yamaguchi; Thomas Prindle; William B Fulton; Sanxia Wang; Paul B McCray; Mark Chappell; David J Hackam; Hongpeng Jia
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2017-09-21       Impact factor: 5.464

8.  Vitamin D-binding protein deficiency in mice decreases systemic and select tissue levels of inflammatory cytokines in a murine model of acute muscle injury.

Authors:  Richard R Kew; Tahmineh Tabrizian; James A Vosswinkel; James E Davis; Randeep S Jawa
Journal:  J Trauma Acute Care Surg       Date:  2018-06       Impact factor: 3.313

9.  Generation of multiple fluid-phase C3b:plasma protein complexes during complement activation: possible implications in C3 glomerulopathies.

Authors:  Mahalakshmi Ramadass; Berhane Ghebrehiwet; Richard J Smith; Richard R Kew
Journal:  J Immunol       Date:  2013-12-23       Impact factor: 5.422

10.  Circulating complexes of the vitamin D binding protein with G-actin induce lung inflammation by targeting endothelial cells.

Authors:  Lingyin Ge; Glenda Trujillo; Edmund J Miller; Richard R Kew
Journal:  Immunobiology       Date:  2013-10-14       Impact factor: 3.144

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.